Cargando…
Defining human mesenchymal stem cell efficacy in vivo
Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart disease in human and animal models of...
Autores principales: | Bonfield, Tracey L, Nolan (Koloze), Mary T, Lennon, Donald P, Caplan, Arnold I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987779/ https://www.ncbi.nlm.nih.gov/pubmed/20974000 http://dx.doi.org/10.1186/1476-9255-7-51 |
Ejemplares similares
-
Mesenchymal Stem Cells in Tissue Repair
por: DiMarino, Amy M., et al.
Publicado: (2013) -
Donor‐defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacterium
por: Bonfield, Tracey L., et al.
Publicado: (2021) -
Chronic asthma and Mesenchymal stem cells: Hyaluronan and airway remodeling
por: Goldstein, Benjamin D., et al.
Publicado: (2017) -
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
por: Sutton, Morgan T., et al.
Publicado: (2016) -
Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes
por: Breitman, Maya, et al.
Publicado: (2021)